<VariationArchive RecordType="classified" VariationID="662833" VariationName="NC_000023.11:g.(?_134460292)_(134460385_?)del" VariationType="Deletion" Accession="VCV000662833" Version="9" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-11-11" DateCreated="2019-08-14" MostRecentSubmission="2023-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="653634" VariationID="662833">
      <GeneList>
        <Gene Symbol="HPRT1" FullName="hypoxanthine phosphoribosyltransferase 1" GeneID="3251" HGNC_ID="HGNC:5157" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>Xq26.2-26.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="134460165" stop="134500668" display_start="134460165" display_stop="134500668" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="133594174" stop="133634697" display_start="133594174" display_stop="133634697" Strand="+" />
          </Location>
          <OMIM>308000</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HPRT1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HPRT1">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="LOC107032760" FullName="origin of replication in promoter/intron 1 of HPRT1" GeneID="107032760" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>Xq26.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="134460082" stop="134465691" display_start="134460082" display_stop="134465691" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129929047" FullName="ATAC-STARR-seq lymphoblastoid silent region 21009" GeneID="129929047" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>Xq26.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="134460257" stop="134460436" display_start="134460257" display_stop="134460436" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NC_000023.11:g.(?_134460292)_(134460385_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq26.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" innerStart="134460292" innerStop="134460385" display_start="134460292" display_stop="134460385" variantLength="94" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" innerStart="133594322" innerStop="133594415" display_start="133594322" display_stop="133594415" variantLength="94" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.(?_133594322)_(133594415_?)del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.(?_133594322)_(133594415_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.(?_134460292)_(134460385_?)del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.(?_134460292)_(134460385_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.11:g.(?_134460292)_(134460385_?)del AND multiple conditions" Accession="RCV000820575" Version="7">
        <ClassifiedConditionList TraitSetID="10191">
          <ClassifiedCondition DB="MedGen" ID="C0023374">Lesch-Nyhan syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268117">Partial hypoxanthine-guanine phosphoribosyltransferase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-08-04" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-08-14" MostRecentSubmission="2023-11-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15571220</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17027311</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22157001</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23975452</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9799086</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="10191" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5209" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GOUT, HPRT-RELATED</ElementValue>
                <XRef Type="MIM" ID="300323" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Partial hypoxanthine-guanine phosphoribosyltransferase deficiency</ElementValue>
                <XRef ID="Partial+hypoxanthine-guanine+phosphoribosyltransferase+deficiency/9096" DB="Genetic Alliance" />
                <XRef ID="238007004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HPRT DEFICIENCY, PARTIAL</ElementValue>
                <XRef Type="MIM" ID="300323" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HPRT1 DEFICIENCY, PARTIAL</ElementValue>
                <XRef Type="MIM" ID="300323" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE 1 DEFICIENCY, PARTIAL</ElementValue>
                <XRef Type="MIM" ID="300323" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">HPRT1 disorders, caused by deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGprt), are typically associated with clinical evidence for overproduction of uric acid (hyperuricemia, nephrolithiasis, and/or gouty arthritis) and varying degrees of neurologic and/or behavioral problems. Historically, three phenotypes were identified in the spectrum of HPRT1 disorders: Lesch-Nyhan disease (LND) at the most severe end with motor dysfunction resembling severe cerebral palsy, intellectual disability, and self-injurious behavior; HPRT1-related neurologic dysfunction (HND) in the intermediate range with similar but fewer severe neurologic findings than LND and no self-injurious behavior; and HPRT1-related hyperuricemia (HRH) at the mild end without overt neurologic deficits. It is now recognized that these neurobehavioral phenotypes cluster along a continuum from severe to mild.</Attribute>
                <XRef ID="NBK1149" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16710" />
                <XRef ID="16710" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301328</ID>
                <ID Source="BookShelf">NBK1149</ID>
              </Citation>
              <XRef ID="79233" DB="Orphanet" />
              <XRef ID="C0268117" DB="MedGen" />
              <XRef ID="MONDO:0010299" DB="MONDO" />
              <XRef Type="MIM" ID="300323" DB="OMIM" />
            </Trait>
            <Trait ID="5397" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Lesch-Nyhan syndrome</ElementValue>
                <XRef ID="Lesch+Nyhan+syndrome/4181" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010298" DB="MONDO" />
                <XRef ID="10406007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LNS</ElementValue>
                <XRef Type="MIM" ID="300322" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">HPRT1 disorders, caused by deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGprt), are typically associated with clinical evidence for overproduction of uric acid (hyperuricemia, nephrolithiasis, and/or gouty arthritis) and varying degrees of neurologic and/or behavioral problems. Historically, three phenotypes were identified in the spectrum of HPRT1 disorders: Lesch-Nyhan disease (LND) at the most severe end with motor dysfunction resembling severe cerebral palsy, intellectual disability, and self-injurious behavior; HPRT1-related neurologic dysfunction (HND) in the intermediate range with similar but fewer severe neurologic findings than LND and no self-injurious behavior; and HPRT1-related hyperuricemia (HRH) at the mild end without overt neurologic deficits. It is now recognized that these neurobehavioral phenotypes cluster along a continuum from severe to mild.</Attribute>
                <XRef ID="NBK1149" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7226" />
                <XRef ID="7226" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301328</ID>
                <ID Source="BookShelf">NBK1149</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="pmc">3111012</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3039492</ID>
              </Citation>
              <XRef ID="510" DB="Orphanet" />
              <XRef ID="C0023374" DB="MedGen" />
              <XRef ID="MONDO:0010298" DB="MONDO" />
              <XRef Type="MIM" ID="300322" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1855614" SubmissionDate="2023-02-03" DateLastUpdated="2023-11-11" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="NM_000194.2_Deletion (Exon 1)|MedGen:C0023374;C0268117" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000961292" DateUpdated="2023-11-11" DateCreated="2019-08-14" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15571220</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17027311</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22157001</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9799086</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23975452</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 1 of the HPRT1 gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 1 of the HPRT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HPRT1 are known to be pathogenic (PMID: 15571220, 17027311, 22157001). A similar copy number variant has been observed in individuals with Lesch-Nyhan disease (PMID: 9799086, 23975452). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HPRT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_133594322)_(133594415_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0023374" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268117" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1855614" TraitType="Disease" MappingType="XRef" MappingValue="C0268117" MappingRef="MedGen">
        <MedGen CUI="C0268117" Name="Partial hypoxanthine-guanine phosphoribosyltransferase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1855614" TraitType="Disease" MappingType="XRef" MappingValue="C0023374" MappingRef="MedGen">
        <MedGen CUI="C0023374" Name="Lesch-Nyhan syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

